PCN68 COST-UTILITY ANALYSIS OF DOCETAXEL VERSUS STANDARD REGIMEN IN THE NEOADJUVANT THERAPY OF LOCALLY ADVANCED BREAST CANCER IN POLAND

Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66604-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)66604-1/fulltext
Title : PCN68 COST-UTILITY ANALYSIS OF DOCETAXEL VERSUS STANDARD REGIMEN IN THE NEOADJUVANT THERAPY OF LOCALLY ADVANCED BREAST CANCER IN POLAND
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66604-1&doi=10.1016/S1098-3015(10)66604-1
First page :
Section Title :
Open access? : No
Section Order : 439
Categories :
Tags :
Regions :
ViH Article Tags :